Restructuring is becoming a slightly more common answer to the question, “What moved the business?” It is not a stampede. But the same phrase is turning up in filings from companies dealing with very different problems, from impaired bioprocessing assets to idle factories and lower capital spending.

In the 21-day filing window from September 7 through September 28, 47 companies flagged restructuring or cost reductions. That was 64.4% of the companies that filed, compared with 55.3% in the same-length window one quarter earlier, June 8 through June 30. The share rose about 1.16 times quarter over quarter. The raw number of companies was 47 in both windows, which is why the percentage matters: it controls for how many companies happened to file.

The language also leaned more negative than positive under the supplied keyword tally, with 25 mentions tagged negative and seven positive. The filings themselves show why that count is not a complete mood ring. “Restructuring” can mean dealing with damage, cutting back to fit reality, or making an existing business more efficient.

Donaldson Company tied restructuring-adjacent costs to a market that did not develop as expected. Its filing described an impairment tied to Univercells Technologies and weaker bioprocessing investment.

"The fiscal 2025 impairment expense included $46.6 million related to Univercells Technologies, reflecting lower-than-anticipated bioprocessing capital spending, particularly for early-stage assets, while drug development timelines are longer than previously anticipated."

Donaldson Company, Inc. / 10-K / 2026-09-25

Here, the relevant action is not simply cutting costs. It is recognizing that customers are spending less on early-stage assets and taking longer to develop drugs.

At Culp, restructuring shows up in the capital base. The home-furnishings company said equipment and other property had been shrinking alongside reduced spending.

"Property, Plant, & Equipment Property, plant, and equipment has steadily decreased due to reduced capital spending stemming from current unfavorable macroeconomic conditions within the home furnishings and residential furniture industries, as well as from our recent restructuring activities announced on April 24, 2025."

([CULP](https://jodie.ai/t/CULP) / 10-Q / 2026-09-11)

That is a quieter form of restructuring: fewer dollars going into the factory, against a backdrop the company describes as unfavorable.

H.B. Fuller supplied the more cheerful version. Its gross margin improved, and the company credited both pricing and restructuring actions.

"Gross profit margin increased 120 basis points primarily due to higher product pricing and the impact of restructuring actions."

H.B. Fuller Company / 10-Q / 2026-09-24

The filing does not make restructuring synonymous with distress. At least in this disclosure, it appears alongside a reported margin improvement and higher pricing.

Intuit's filing placed the topic inside corporate overhead. Unallocated corporate items rose as research and development, restructuring costs and cost of service revenue increased.

"Unallocated corporate items increased in fiscal 2026 compared with fiscal 2025 due to increases in research and development expense, restructuring costs, and cost of service revenue."

Intuit Inc. / 10-K / 2026-09-09

That is a different use of the same management vocabulary: restructuring as part of the expense line, not necessarily a single facility closure or a discrete turnaround.

NAII's version was more physical. The company said it grew sales but still lost money because its available factory capacity was underused, with an impairment charge following.

"While we grew our net sales during fiscal 2026, we experienced a loss during fiscal 2026 that was primarily due to underutilization of our available factory capacities which also led to an impairment charge of one of our facilities and related assets."

NAII / 10-K / 2026-09-28

Across these filings, restructuring is less a single economic diagnosis than a shared management response. Companies are trimming capital spending, absorbing impairments, working through excess capacity, incurring restructuring costs or reporting better margins alongside restructuring actions. The measurable change is modest: the topic is appearing in a larger share of filings, not that every company suddenly has the same problem.

This is a descriptive reading of SEC filings via jodie's analytics, not investment advice.